Investors who are attending Cupid AGM, please see if you can ask the following questions:
1) Can you please let us know what are the different channels of revenue and also please break up the sale percentage between them
(like Govt orders, Exports to clients, Contract manufacturing & Brand selling from online / distributors) ? And which of the following segment you think will
grow fast in future ?
2) Can you please let us know the margins of Male Condoms and Female Condoms ?
3) What is the percentage of sales going into R&D activities ?
4) As our capacities are very much under utilized (which is in a way good for us in terms of future minimal Capex requirement perspective), 37% utilization of
male condoms & 67% utilization of female condoms. When do you expect the utilization of reach a optimal levels of around 60% to 70% in male categories and
how much it will cost (Time & money) to convert any male facility into female facility if needed, based on the demand ?
5) How is the response from e-commerce sales ?
6) Regarding the new product Lubricant jelly: Has the product launch happened already ?
What is the growth prospects you are looking at your new product Lubricant jelly ?
Is it a B2C product or supplied to clients (B2B) ? And what are the margins expected from this new product ?
7) In your website you mentioned ther is a possibility of adding new products like sanitary napkins, Adult & Baby Diapers into the market by the Cupid brand.
But as this market segment is already dominated by the big players like Procter and Gamble, Whisper, Johnson & Johnson etc and do you think we can make a
difference among those well established players, without burning much of the cash ?
8) Is the company open for a strategic buyout by some other big pharma player in industry. If any such offer comes, are you willing to move forward ?
9) There is an grape wine that, Cupid is planning for a JV with Piramal enterprises. Can you please comment on the same ? Or do you have any JV plans in future ?
Best Regards.
Subscribe To Our Free Newsletter |